ClinicalTrials.Veeva

Menu

A Registered Cohort Study on Amyotrophic Lateral Sclerosis

F

Fujian Medical University (FJMU)

Status

Enrolling

Conditions

Amyotrophic Lateral Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT04008329
MRCTA,ECFAH of FMU [2019]191

Details and patient eligibility

About

Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.

Full description

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND), which is characterized with highly clinical heterogeneity and no effective treatment is available now. The purpose of this registered cohort is to observe the natural history of ALS patients in China, and then identify some factors correlated with disease progression. Besides, ALS-related gene mutations will be screened and explore novel disease causing gene as well.

Enrollment

2,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Amyotrophic Lateral Sclerosis patients fulfilling the El Escorial criteria (including definite, probable and possible)
  • Progressive muscular atrophy
  • Primary lateral sclerosis
  • Progressive bulbar palsy

Exclusion criteria

  • History of serious head trauma or neuropsychiatric disease
  • Decline to participate

Trial contacts and locations

1

Loading...

Central trial contact

Qi-Jie Zhang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems